[{"address1": "121 Richmond Street West", "address2": "Penthouse Suite, 1300", "city": "Toronto", "state": "ON", "zip": "M5H 2K1", "country": "Canada", "website": "https://www.psyence.com", "industry": "Drug Manufacturers - General", "industryKey": "drug-manufacturers-general", "industryDisp": "Drug Manufacturers - General", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Psyence Group Inc., a life science biotechnology company, engages in the commercial psilocybin mushroom cultivation and production activities. Its natural psilocybin is used for the treatment of a range of mental health disorders and other medical conditions. The company is developing pharmaceutical preparations of psilocybin doses to help heal psychological trauma and diagnosable disorders, including anxiety, depression, post-traumatic stress disorder, and grief and bereavement. It also focuses on the development, distribution, and sale of over-the-counter non psilocybin containing functional mushroom nutraceutical products under the GOODMIND brand. The company was founded in 2019 and is based in Toronto, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Jody  Aufrichtig", "age": 49, "title": "Co-Founder & Executive Chairman", "yearBorn": 1974, "fiscalYear": 2023, "totalPay": 110367, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Neil  Maresky M.D.", "age": 58, "title": "CEO & Director", "yearBorn": 1965, "fiscalYear": 2023, "totalPay": 250165, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alan Mark Friedman B.Com., Bcomm, Bproc Law", "age": 51, "title": "Co-Founder & Director", "yearBorn": 1972, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Warwick Ron Corden-Lloyd", "age": 43, "title": "CFO & Corporate Secretary", "yearBorn": 1980, "fiscalYear": 2023, "totalPay": 110367, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Taryn  Vos", "title": "General Counsel", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tony  Budden", "title": "Chief Strategy Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Mary-Elizabeth  Gifford", "title": "Executive Vice President for Public Policy & Global Impact", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Clive  Ward-Able BPharm, M.D.", "title": "Medical Director and Head of R&D and Early Commercialization", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.0232, "open": 0.0232, "dayLow": 0.0232, "dayHigh": 0.0232, "regularMarketPreviousClose": 0.0232, "regularMarketOpen": 0.0232, "regularMarketDayLow": 0.0232, "regularMarketDayHigh": 0.0232, "beta": 0.214, "volume": 1000, "regularMarketVolume": 1000, "averageVolume": 2443, "averageVolume10days": 100, "averageDailyVolume10Day": 100, "marketCap": 3188561, "fiftyTwoWeekLow": 0.0129, "fiftyTwoWeekHigh": 0.8921, "fiftyDayAverage": 0.03074, "twoHundredDayAverage": 0.08977095, "currency": "USD", "enterpriseValue": 3018206, "floatShares": 131495355, "sharesOutstanding": 137438000, "heldPercentInsiders": 0.03881, "impliedSharesOutstanding": 236608000, "bookValue": 0.004, "priceToBook": 5.7999997, "lastFiscalYearEnd": 1680220800, "nextFiscalYearEnd": 1711843200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -5131267, "trailingEps": -0.04, "enterpriseToEbitda": -0.486, "52WeekChange": -0.7986111, "SandP52WeekChange": 0.30279303, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "PSYGF", "underlyingSymbol": "PSYGF", "shortName": "PSYENCE GROUP INC", "longName": "Psyence Group Inc.", "firstTradeDateEpochUtc": 1654003800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "5781b508-51cf-39d5-8fbe-9a540a0551c1", "messageBoardId": "finmb_682094975", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.0232, "recommendationKey": "none", "totalCash": 213451, "totalCashPerShare": 0.002, "ebitda": -6208492, "totalDebt": 43092, "quickRatio": 0.271, "currentRatio": 0.314, "debtToEquity": 7.745, "returnOnAssets": -1.36157, "returnOnEquity": -3.97218, "freeCashflow": -3095992, "operatingCashflow": -4090589, "financialCurrency": "CAD", "trailingPegRatio": null}]